GLP-1 Medications for PCOS: A Complete Guide

Why GLP-1s Work for PCOS

PCOS (Polycystic Ovary Syndrome) is fundamentally a metabolic and hormonal condition driven by insulin resistance. GLP-1 medications address PCOS at its root by improving insulin sensitivity, reducing androgen levels, and promoting weight loss. Studies show GLP-1s can restore menstrual regularity in 40-60% of women with PCOS, improve fertility outcomes, and reduce hirsutism. The weight loss achieved (typically 10-15%) often restores ovulation in overweight women. Additionally, GLP-1s may directly affect ovarian function and reduce systemic inflammation associated with PCOS. For women with PCOS and prediabetes or type 2 diabetes, GLP-1s offer dual benefits. Even lean women with PCOS may benefit from GLP-1s' metabolic effects. As insulin sensitivity improves, many women see reductions in testosterone levels, leading to clearer skin, less hair growth, and improved mood.

Treatment Approach

While not specifically FDA-approved for PCOS, GLP-1s are increasingly prescribed off-label with excellent results. Liraglutide (Saxenda) has the most PCOS-specific data, while semaglutide offers superior convenience and weight loss. Many reproductive endocrinologists use GLP-1s before fertility treatments to improve outcomes. Metformin remains first-line for PCOS metabolic management, but GLP-1s are added when metformin is insufficient. If trying to conceive, discuss timing with your provider—GLP-1s should be stopped once pregnancy is confirmed. SeraVia formulations support hormonal balance and metabolic health for women managing PCOS alongside GLP-1 therapy. Regular monitoring of menstrual cycles, metabolic markers, and androgen levels helps track progress.

FAQs